Das Medizinportal
Menü

Literatur:

Schwerpunkt Auge + Alter

 

Glaukom und trockenes Auge – Zufall, Folge oder mehr?

Anselm G. M. Jünemann

Seiten 13–19

  1. Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II. Definition and Classification report. Ocul Surf 2017a; 15:276e83
  2. Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, de Paiva CS, Gomes JAP, Hammitt KM, Jones L, Nichols JJ, Nichols KK, Novack GD, Stapleton FJ, Willcox MDP, Wolffsohn JS, Sullivan DA. TFOS DEWS II Report Executive Summary. Ocul Surf. 2017b;15: 802-812
  3. Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int 2015; 112:71–81
  4. Erb C, Gast U, Schremmer D. German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefes Arch Clin Exp Ophthalmol 2008; 246:1593-1601
  5. Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 2010; 29:618-621
  6. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008; 17:350-355
  7. Kuppens EV, van Best JA, Sterk CC, de Keizer RJ. Decreased basal tear turnover in patients with untreated primary open-angle glaucoma. Am J Ophthalmol 1995; 120:41-46
  8. Erdoğan H, Arici DS, Toker MI, Arici MK, Fariz G, Topalkara A. Conjunctival impression cytology in pseudoexfoliative glaucoma and pseudoexfoliation syndrome. Clin Exp Ophthalmol 2006; 34:108-113
  9. Rosentreter A, Neuburger M, Jordan JF, SchildAM, Dietlein TS. Einflußgrößen auf die Applanationstonometrie – ein praxisorientierter Überblick. Klin Monatsbl Augenheilkd 2011; 228: 109-113
  10. Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, Aihara M, Amano S. Effects of long-term topical anti-glaucoma medications on meibomian glands. Graefes Arch Clin Exp Ophthalmol 2012; 250:1181-1185
  11. Uzunosmanoglu E, Mocan MC, Kocabeyoglu S, et al. Meibomian gland dysfunction in patients receiving long-term glaucoma medications. Cornea 2016; 35:1112–1116
  12. Heiligenhaus A, Koch JM, Kruse FE, Schwarz C, Waubke TN. Diagnosis and and differentiation of dry eye disorders. Ophthalmologe 1995, 92:6–11
  13. Tong L, Chaurasia SS, Mehta JS, Beuerman RW. Screening for meibomian gland diseas its relation to dry eye subtypes and symptoms in a tertiary referral clinic in singapore. Invest OphthalmolVis Sci 2010; 51:3449–3454
  14. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: aretrospectivestudy. Cornea 2012; 31:472–478

 

Digitale Kataraktchirurgie: Planung, Markierung und Tracking bei torischer Linsenimplantation

Wolfgang J. Mayer

Seiten 20–21

  1. Visser N, Berendshot TT, Bauer NJ, Jurich J, Kersting O, Nuijts RM. Accuracy of toric intraocular lens implantation in cataract and refractive surgery. J Cataract Refract Surg 2011; 37: 1394-402.
  2. Viestenz A, Seitz B, Langenbucher A. Evaluating the eye´s rotational stability during standard photography: effect on determining the axial orientation of toric intraocular lenses. J Cataract Refract Surg 2005; 31. 557-61.
  3. Mayer WJ, Kreutzer T, Dirisamer M, Kern C, Kortuem K, Vounotrypidis E, Priglinger S, Kook D. Comparison of visual outcomes, alignment accuracy, and surgical time between 2 methods of corneal marking for toric intraocular lens implantation. J Cataract Refract Surg. 2017 Oct;43(10):1281-1286.

 

Erste Interimsanalyse der Registerstudie IDEAL: Behandlung des diabetischen Makulaödems mittels eines intravitrealen Fluocinolonacetonid-Implantats

Ramin Khoramnia

Seiten 22–23

  1. Koch FH et al., ARVO 2019, Vancouver, Poster B0153
  2. Khoramnia R et al., ARVO-Kongress 2019, Vancouver Poster B0150

 

Warum Netzhautuntersuchungen so wichtig sind und wie die Retina Risk App Diabetiker unterstützen kann

Ray Snyder, Sigurbjörg Jonsdottir, Aegir Thor Steinarsson, Sibylle Scholtz, Prof. Dr. Einar Stefansson

Seiten 24–27

  1. Karinya Lewis, I wish someone had told me …, Comm Eye Health Vol. 24 No. 75 2011 pp 10-11. https://www.cehjournal.org/article/i-wish-someone-had-told-me/

 

Visuelle Rehabilitation mit dem subretinalen photovoltaischen Implantat

Efstathios Vounotrypidis

Seiten 28–32

  1. Goetz GA, Palanker DV. Electronic approaches to restoration of sight. Rep Prog Phys. 2016;79(9):096701.
  2. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106-16.
  3. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379(9827):1728-38.
  4. Mathieson K, Loudin J, Goetz G, Huie P, Wang L, Kamins TI, et al. Photovoltaic Retinal Prosthesis with High Pixel Density. Nat Photonics. 2012;6(6):391-7.
  5. Wang L, Mathieson K, Kamins TI, Loudin JD, Galambos L, Goetz G, et al. Photovoltaic retinal prosthesis: implant fabrication and performance. J Neural Eng. 2012;9(4):046014.
  6. Palanker D, Vankov A, Huie P, Baccus S. Design of a high-resolution optoelectronic retinal prosthesis. J Neural Eng. 2005;2(1):S105-20.
  7. Goetz GA, Mandel Y, Manivanh R, Palanker DV, Cizmar T. Holographic display system for restoration of sight to the blind. J Neural Eng. 2013;10(5):056021.
  8. Lorach H, Wang J, Lee DY, Dalal R, Huie P, Palanker D. Retinal safety of near infrared radiation in photovoltaic restoration of sight. Biomed Opt Express. 2016;7(1):13-21.
  9. Loudin JD, Simanovskii DM, Vijayraghavan K, Sramek CK, Butterwick AF, Huie P, et al. Optoelectronic retinal prosthesis: system design and performance. J Neural Eng. 2007;4(1):S72-84.
  10. Asher A, Segal WA, Baccus SA, Yaroslavsky LP, Palanker DV. Image processing for a high-resolution optoelectronic retinal prosthesis. IEEE Trans Biomed Eng. 2007;54(6 Pt 1):993-1004.
  11. Lorach H, Goetz G, Smith R, Lei X, Mandel Y, Kamins T, et al. Photovoltaic restoration of sight with high visual acuity. Nat Med. 2015;21(5):476-82.
  12. Lorach H, Goetz G, Mandel Y, Lei X, Galambos L, Kamins TI, et al. Performance of photovoltaic arrays in-vivo and characteristics of prosthetic vision in animals with retinal degeneration. Vision Res. 2015;111(Pt B):142-8.
  13. Lei X, Kane S, Cogan S, Lorach H, Galambos L, Huie P, et al. SiC protective coating for photovoltaic retinal prosthesis. J Neural Eng. 2016;13(4):046016.
  14. Lee DY, Lorach H, Huie P, Palanker D. Implantation of Modular Photovoltaic Subretinal Prosthesis. Ophthalmic Surg Lasers Imaging Retina. 2016;47(2):171-4.
  15. Ho E, Smith R, Goetz G, Lei X, Galambos L, Kamins TI, et al. Spatiotemporal characteristics of retinal response to network-mediated photovoltaic stimulation. J Neurophysiol. 2018;119(2):389-400.
  16. Palanker DV. Photovoltaic restoration of sight in age-related macular degeneration. .  Invest Ophthalmol Vis Sci 2019;60(9):2.
  17. Palanker DV, Le Mer Y, Hornig R, Buc G, Deterre M, Bismuth V, et al. Restoration of Sight in Geographic Atrophy using a Photovoltaic Subretinal Prosthesis.  Invest Ophthalmol Vis Sci 2019;60(9):970.
  18. Flores T, Lei X, Huang T, Lorach H, Dalal R, Galambos L, et al. Optimization of pillar electrodes in subretinal prosthesis for enhanced proximity to target neurons. J Neural Eng. 2018;15(3):036011.
  19. Ho E, Lei X, Flores TA, Lorach H, Huang TW, Galambos L, et al. Characteristics of prosthetic vision in rats with subretinal flat and pillar electrode arrays. J Neural Eng. 2019.
  20. Flores T, Huang T, Bhuckory M, Ho E, Chen Z, Dalal R, et al. Honeycomb-shaped electro-neural interface enables cellular-scale pixels in subretinal prosthesis. Scientific reports. 2019;9(1):10657.